Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Beta-hydroxysteroid dehydrogenase deficiency is a rare genetic disorder caused by a mutation in the HSD3B2 gene. This gene is responsible for producing an enzyme called beta-hydroxysteroid dehydrogenase, which is involved in the metabolism of steroid hormones. When this enzyme is deficient, the body is unable to properly metabolize steroid hormones, leading to a variety of symptoms, including low levels of cortisol, a hormone that helps regulate blood pressure, glucose levels, and the body's response to stress. Other symptoms may include low levels of sex hormones, such as testosterone and estrogen, as well as an increased risk of developing certain types of cancer. Treatment typically involves hormone replacement therapy and lifestyle modifications.
All of the following must be considered when interpreting
clinical findings and are too extensive to be covered on
this site: